[Effect of invisible appliance without bracket and self-locking bracket appliance on periodontal and subgingival flora in patients with periodontitis].

PURPOSE: To observe the effect of non-bracket invisible appliance and self-locking bracket appliance on periodontal health and subgingival flora in patients with periodontitis. METHODS: One hundred and ten patients with periodontitis who received orthodontic treatment were divided into invisible group and self-locking bracket group. The periodontal index including probing depth (PD), gingival index (GI), sulcular bleeding index (SBI) and plaque index (PLI) ，and the levels of inflammatory factors in the gingival crevicular fluid were examined. Visual analogue scale (VAS) was used to evaluate periodontal pain before and after correction, and the curative effect was evaluated. The status of common pathogenic bacteria in the subgingival plaque of patients after correction was detected by PCR. The data were analyzed with SPSS19.0 software package. RESULTS: Twelve months after treatment and at the end of treatment, PLI of the self-locking bracket group was significantly higher than the invisible group(P＜0.05), but PD, GI and SBI between the two groups had no significant difference. After correction, the inflammatory factors in the invisible group were significantly lower than those in the self-locking bracket group(P＜0.05). At 1d after treatment, pain index in the invisible group was significantly lower than the self-locking group(P＜0.05). The clinical total effective rate of the invisible group was significantly higher than the self-locking group (89.10% vs 76.36%). After treatment, the detection rate and the content of subgingival pathogenic bacteria in the self-locking bracket group were significantly higher than the invisible group(P＜0.05). CONCLUSIONS: During orthodontic treatment of periodontitis, wearing non-bracket invisible appliance can effectively inhibit inflammatory response and proliferation of subgingival pathogens, which is more conducive to the maintenance of periodontal health and oral hygiene.

Sacral and thoracic chordoma with pulmonary metastases: A case report and review of the literature.

Chordoma is a sporadic type of cancer that affects the spine and is particularly challenging to treat due to the paucity of reported cases and scientific literature. In particular, primary chordomas affecting both the sacral and thoracic vertebrae are extremely rare. We herein report a rare case of chordoma in the sacral and thoracic vertebrae with pulmonary metastasis, along with a literature review. The objective of the present study was to explore treatment options and long-term outcomes in patients with metastatic chordoma. Posterior decompression was performed for the thoracic tumor, followed by extended resection of the sacral tumor. The symptoms of the patient were relieved after surgery, and the postoperative Nurick score decreased from grade 3 to grade 2, while the postoperative McCormick score was I. Therefore, complete chordoma excision and internal spinal fixation may effectively reduce tumor recurrence and metastasis.

1-[(6-Chloro-pyridin-3-yl)meth-yl]-10-nitro-1,2,3,5,6,7,8,9-octa-hydro-5,9-methano-imidazo[1,2-a]azocin-5-ol.

In the title compound, C16H19ClN4O3, the cyclo-hexane ring displays a chair formation and the tetra-hydro-pyridine ring displays an envelope conformation with the methyl-ene C atom as the flap; the imidazolidine ring also displays an envelope conformation with a methyl-ene C atom as the flap. In the crystal, O-H⋯N hydrogen bonds between hy-droxy groups and pyridine rings link inversion-related mol-ecules into dimers. Weak C-H⋯O hydrogen bonds further link the dimers into supra-molecular chains running along the c axis.

Preparation and evaluation of self-microemulsifying drug delivery system containing vinpocetine.

The main purpose of current investigation is to prepare a self-microemulsifying drug delivery system (SMEDDS) to enhance the oral bioavailability of vinpocetine, a poorly water-soluble drug. Suitable vehicles were screened by determining the solubility of vinpocetine in them. Certain surfactants were selected according to their emulsifying ability with different oils. Ternary phase diagrams were used to identify the efficient self-microemulsifying region and to screen the effect of surfactant/cosurfactant ratio (K(m)). The optimized formulation for in vitro dissolution and bioavailability assessment was oil (ethyl oleate, 15%), surfactant (Solutol HS 15, 50%), and cosurfactant (Transcutol P, 35%). The release rate of vinpocetine from SMEDDS was significantly higher than that of the commercial tablet. Pharmacokinetics and bioavailability of SMEDDS were evaluated. It was found that the oral bioavailability of vinpocetine of SMEDDS was 1.72-fold higher as compared with that of the commercial tablet. These results obtained demonstrated that vinpocetine absorption was enhanced significantly by employing SMEDDS. Therefore, SMEDDS might provide an efficient way of improving oral bioavailability of poorly water-soluble drugs.